FTC, Express Scripts Reach Landmark Settlement to Lower Insulin Prices

The Federal Trade Commission settlement also calls for Express Scripts to reshore its group purchasing organization, Ascent, from Switzerland to the U.S.

Express Scripts headquarters, one of the largest U.S. pharmacy benefits management companies, in Berkeley, Mo., in 2011. Jeff Roberson/AP Photo

The Federal Trade Commission (FTC) and pharmacy benefit manager Express Scripts, Inc. have reached what the FTC called a landmark settlement of a lawsuit brought by the agency, alleging that the company artificially inflated insulin drug prices.

According to a Feb. 4 FTC statement, Express Scripts will now be required to adopt “fundamental changes to its business practices that increase transparency.”